LUBBOCK, Texas -- A new trial is being offered at the Joe Arrington Cancer Center available for those needing help treating prostate cancer, Pluvicto.

"Pluvicto is an IV medication that targets prostate cancer cells and delivers radiation in a short range," said Dr. Eduardo Urias, a Radiation Oncologist at the Covenant Health Cancer Institute.